Vancouver, BC, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor…
Reports third quarter 2025 total revenue of $7.8 million, representing 3% growth compared to the third quarter of 2024. Third quarter…
The company’s unique qubit modality and architecture successfully met Stage A requirements, positioning Photonic for the next phase of validation…
To commemorate two decades since its groundbreaking 3-in-1 coffee press debuted, the iconic coffee press is expanding its lineup with…
NEW ORLEANS, Nov. 05, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until…
Integration Reinforces FreshCloud as the Industry's Most Connected Digital Quality Ecosystem PHILADELPHIA, Nov. 5, 2025 /PRNewswire/ -- AgroFresh Solutions, Inc.,…
November 05, 2025 08:00 ET | Source: LENZ Therapeutics, Inc. VIZZTM (aceclidine ophthalmic solution) 1.44% received FDA approval for the…
Metabolon to Support Landmark Million Veteran Program 62,000-sample Dataset Advancing Veteran Health and Multiomics Research MORRISVILLE, N.C., Nov. 4, 2025…
Key Findings: Critical infrastructure in the energy sector experienced a 387% increase in attacks compared to the previous yearIndia continues…
DALLAS, Nov. 4, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc. announced today positive long-term safety results from its EXTEND study, a…